The product is a human anti-SLC1A5 antibody hexamer with enhanced complement-dependent cytotoxicity (CDC) activity. This hexameric IgG1 targets both human and cynomolgus SLC1A5 and includes mutations that enhance hexamerization. These hexamerization-enhancing mutations promote optimal C1q binding, thereby boosting CDC activity.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-1002CLV | Anti-Human SLC1A5 Recombinant Antibody (TAB-1002CLV) | ELISA | |
TAB-1003CLV | Anti-Human SLC1A5 Recombinant Antibody (TAB-1003CLV) | FC, Inhib | |
TAB-1004CLV | Anti-Human SLC1A5 Recombinant Antibody (TAB-1004CLV) | FC, Inhib | |
TAB-1005CLV | Anti-Human SLC1A5 Recombinant Antibody (TAB-1005CLV) | FC, Inhib | |
TAB-1006CLV | Anti-Human SLC1A5 Recombinant Antibody (TAB-1006CLV) | FC, Inhib |
There are currently no Customer reviews or questions for VS-0924-YC150. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.